World-class radiotherapy in the UK
Led by the All Party Parliamentary Group for Radiotherapy, the [...]
Summary of kidney cancer highlights from ASCO GU 2024
This year’s American Society of Clinical Oncology Genitourinary Cancers (ASCO [...]
Cancer treatment could identify patients most likely to respond to cancer drugs
Scientists from Cancer Research UK and Memorial Sloan Kettering Cancer [...]
Belzutifan and shows better quality of life compared to everolimus
People with kidney cancer have been shown to have changes [...]
Lenvatinib plus pembrolizumab for advanced kidney cancer
The final survival information from the phase 3 CLEAR study [...]
Patient’s perspective on pembrolizumab/lenvatinib for kidney cancer
In 2009, Cesar Fuentes was first diagnosed with kidney cancer [...]
METEOR study: Cabozantinib compared to everolimus in advanced kidney cancer
Cabozantinib is a tyrosine kinase inhibitor that is used [...]
‘No stupid questions’ for newly diagnosed kidney cancer patients
In this recent video interview, Dr Rachel Giles, chief executive [...]
Cancer signs on urinal mats in pubs and football grounds
The NHS are putting urinal mats in public places in [...]
Belzutifan for advanced kidney cancer: long-term follow-up
Studies looking at the genes of people with kidney cancer have shown [...]
